References
- Koch G, Johansson V, Arvidsson E. Radio-enzymatic determination of epinephrine, norepinephrine and dopamine in 0.1 ml plasma samples. Plasma catecholamine response to sub-maximal and near maximal exercise. J Clin Chem Clin Biochem 1980; 18: 367–72
- Franz I W, Lohmann F W, Koch G. Differential effects of long-term cardioselective and nonselective beta-receptor blockade on plasma catecholamines during and after physical exercise in hypertensive patients. J Cardiovasc Pharmacol 1980; 2: 35–44
- Schnabel A, Kindermann W, Salas-Fraire O, Cassens J, Steinkraus V. Effect of beta-adrenergic blockade on supramaximal exercise capacity. Int J Sports Med 1983; 4: 278–81
- Eriksen J, Thaulow E, Mundal R, Opstad P, Nitter-Hauge S. Comparison of beta-adreno-receptor blockers under maximal exercise. Br J Clin Pharmac 1982; 13: 201S–9S
- Irving M H, Britton B J, Wood W G, Padgham C, Carruthers M. Effects of beta adrenergic blockade on plasma catecholamines in exercise. Nature 1974; 248: 531–3
- Holaday J W. Cardiovascular effects of endogenous opiate systems. Ann Rev Pharmacol Toxicol 1983; 23: 541–94
- Farsang C, Kunos G. Naloxone reverses the antihypertensive effect of clonidine. Br J Pharmacol 1979; 67: 161–4
- Grossman A, Bouloux P, Price P, Drury P L, Lam K SL, Turner T, Besser G M, Sutton J. The role of opioid peptides in the hormonal responses to acute exercise in man. Clin Sci 1984; 67: 483–91
- Bramnert M, Høkfelt B. Lack of effect of naloxone in a moderate dosage on the exercise-induced increase in blood pressure, heart rate, plasma catecholamines, plasma renin activity and plasma aldosterone in healthy males. Clin Sci 1985; 68: 185–91
- Peuler J D, Johnson G A. Simultaneous single radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 1977; 21: 625–36
- Kjeldsen S E, Flaaten B, Eide I, Helgeland A, Leren P. Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension. Scand J Clin Lab Invest 1982; 42: 217–23
- Rubin P C, Blaschke T F, Guilleminalt C. Effect of naloxone, a spesific opioid inhibitor, on blood pressure fall during sleep. Circulation 1981; 63: 117–21
- Bouloux P, Grossman A, Lytras N, Besser G M. Evidence for the participation of endogenous opioids in the sympathoadrenal response to hypoglycemia in man. Clin Endocrinol 1985; 22: 49–56
- Lam K SL, Grossman A, Bouloux P, Drury P L, Besser G M. Effect of an opiate antagonist on the responses of circulating catechlamines and the renin-aldorsterone system to acute sympathetic stimulation by hand-grip in man. Acta Endocrinol 1986; 111: 252–7
- Jaffe J H, Martin W R. Narcotic analgesics and antagonist. The Pharmacological Basis of Therapeutics, L S Goodman, A Gilman. Macmillan publishing Co, New York 1975; 274
- Sawynok J, Pinsky C, La Bella F S. Minireview on the specificity of naloxone as an opiate antagonist. Life Sci 1979; 25: 1621–32
- Sugewara K, Takami N, Maemura S, Niva M, Ozaki M. Beta-adrenoreceptor blocking agents release catecholamines from rat adrenal medulla. European J Pharmacol 1980; 62: 287–95
- Galbo H, Hoist J J, Christensen N J. Glucagon and plasma catecholamines during beta-receptor blockade in exercising man. J Appl Physiol 1976; 40: 855–63
- Best J D, Halter J B. Release and clearance rates of epinephrine in man. Importance of arterial measurements. J Clin Endocrinol Metab 1982; 55: 263–8
- Rand M J, Majewski H, Medgett I C, McCulloch M W, Story D F. Prejunctional receptors modulating autonomic neuroeffector transmission. Clin Res 1980; 46: 70–6
- Esler M, Jackman G, Leonard P, Skews H, Bobik A, Jennings G. Effect of propranolol on noradrenaline kinetics in patients with essential hypertension. Br J Clin Pharm 1981; 12: 375–80